Characterization and Prediction of Natriuretic Peptide “Nonresponse” During Heart Failure Management: Results From the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions an
Author:
Affiliation:
1. Cardiology Division; Massachusetts General Hospital; Boston; MA
2. Cardioendocrine Research Group; University of Otago Christchurch; Christchurch; New Zealand
Publisher
Wiley
Subject
Cardiology and Cardiovascular Medicine,Emergency,Emergency Medicine
Reference24 articles.
1. Clinical epidemiology of heart failure: public and private health burden;McMurray;Eur Heart J,1998
2. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed In Collaboration With the International Society For Heart And Lung Transplantation;Hunt;J Am Coll Cardiol,2009
3. Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching;Kinnunen;Endocrinology,1993
4. Natriuretic peptides: physiologic and analytic considerations;Omland;Heart Fail Clin,2009
5. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study;Januzzi;Am J Cardiol,2005
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Natriuretic peptide testing strategies in heart failure: A 2023 update;Advances in Clinical Chemistry;2024
2. Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection Fraction;JACC: Heart Failure;2023-12
3. Combined Left Ventricular Ejection Fraction and N-Terminal pro-B-type Natriuretic Peptide after Sacubitril/Valsartan for Predicting Outcomes in Patients with Heart Failure with Reduced Ejection Fraction;ACTA CARDIOL SIN;2023
4. Vericiguat and NT‐proBNP in patients with heart failure with reduced ejection fraction: analyses from the VICTORIA trial;ESC Heart Failure;2022-07-26
5. Sacubitril/valsartan in Heart Failure and Beyond—From Molecular Mechanisms to Clinical Relevance;Reviews in Cardiovascular Medicine;2022-06-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3